Available Forms: Tablets
Available Strengths: 1 mg, 2.5 mg
Reference Brands: Amerge (USA/EU)
Category: Neurology
Quick Response Guaranteed | Verified Suppliers
Product Description:
Naratriptan is a medication used for the treatment of acute migraine attacks and the associated symptoms of migraine. These symptoms commonly include severe, throbbing headaches that may be accompanied by nausea and increased sensitivity to light or sound. Naratriptan is not intended for the prevention of migraines but is used to relieve symptoms once a migraine attack has started.
Naratriptan is marketed under brand names such as Amerge and Naramig and belongs to a class of medicines known as triptans. It is a selective serotonin 5-HT1 receptor agonist that works by targeting specific serotonin receptors in the brain. By activating these receptors, naratriptan helps narrow dilated blood vessels and reduce inflammatory processes believed to contribute to migraine pain.
This targeted mechanism of action helps alleviate headache intensity and associated migraine symptoms. Naratriptan is widely used in clinical practice and is effective when taken at the onset of migraine symptoms, helping patients regain normal functioning during migraine episodes when used as prescribed under medical supervision.
Naratriptan is used for the acute treatment of migraine attacks with or without aura in adults.
Naratriptan is a synthetically manufactured triptan produced through chemical synthesis.
The trade name of naratriptan is Amerge.
Amerge was originally developed and marketed by GlaxoSmithKline (GSK). Generic versions are produced by multiple manufacturers worldwide.
The generic name of Naratriptan is naratriptan hydrochloride.
The brand name of Naratriptan is Amerge, along with various generic equivalents.
Naratriptan is manufactured in multiple countries including the United States, India, and EU nations, depending on the manufacturer and regulatory approvals.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP